Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Bacteroides fragilis NCTC 9343, ATCC 25285 = NCTC 9343

>BF3384 putative xanthine/uracyl permease, membrane protein
MKTDLIYGIEDRPPFKDALFAALQHLLAIFVAIITPPLIIASALKLDVEK
TGFLVSMSLFASGVSTFIQCRRFGPIGAKLLCIQGTSFSFIGPIIATGLV
GGLPLIFGVCMAAAPIEMIISRTFKYMRNIITPLVSGIVVLLIGLSLIKV
GIISCGGGYTAMDNGTFASWENLSIAGAVLLSVLFFNRCKNKYLRMSSIV
LGLCLGYGLAFVLGKVDMSALNVEMLMSFNIPQPFKYGLDFNVSSFIAIG
LVYMITAIEATGDVTANSMISGLKIEGDDYLKRVSGGVMADGFNSFLAGI
FNSFPNSIFAQNNGIIQLTGVASRYVGYYIAAMLILLGLFPIVGAVFSLM
PDPVLGGATLLMFGTVAAAGIRIVASQNIGRKETLVLAVSLSLGLGVELM
PDVLSQAPEAIRSIFSSGITTGGLTAIIANIVIRVKEENEE
>BF2659 putative phosphoribosylpyrophosphate amidotransferase
MEQLKHECGVAMIRLLKPLEYYEKKYGTWMYGLNKLYLLMEKQHNRGQEG
AGLACVKLEANPGEEYMFRERALGSGAITEIFETVQSNFKDLSKEQLHDA
AFAKRTLPFAGEAYMGHLRYSTTGKSGISYVHPFLRRNNWRAKNLALCGN
FNMTNVDEIFARITAIGQHPRKYADTYIMLEQVGHRLDREVERLFNLAEA
EGLTGMGVTHYIEDHIDLANVLRTSSKEWDGGYVMCGLTGSGESFALRDP
WGIRPAFWYQDDEIAVLASERPVIQTALNVPIGEIRELLPGQALLISKEG
KLRTAQINKAREKKACSFERIYFSRGSDADIYKERKQLGEKLVPNILKAI
DNDLDHTVFSFIPNTAEVAFYGMLQGLDNYLNEEKVRQIASLGHHPDHDE
LEVILSRRIRSEKVAIKDIKLRTFIAEGNSRNDLAAHVYDITYGSLRSGI
DNLVIIDDSIVRGTTLKQSIIGILDRLGPKKIVIVSSSPQVRYPDYYGID
MAKMSEFIAFKAAIELLKDRDMKDVIASAYRKSKDQVGLPKEQMVNYVKD
IYAPFTDEEISEKMVELLTPKGTKAKVQIVYQPLEGLHEACPNHTGDWYF
SGNYPTPGGVKLLNEAFINYIEQVYQF
>BF2354 conserved hypothetical protein
MHDIPKQIPLANNHISVDCVVIGFDGEQLKVLLINRIGEENGKVYRDMKL
PGSLIYMDEDLDEAAQRVLFELTGIRNVNLMQFKAFGSKNRTSNPKDVHW
LERAMQSKVERIVTIAYLSMVKIDRALDKNLDEFQACWVALKDIKTLAFD
HNLIIREALTYIRQFVEFNPSMLFDLLPRKFTASQLRILFELVYDKAVDV
RNFHKKIALMDYVVPLEEKQTGVAHRAARYYKFDRKIYNKTRR
>BF0514 putative 5'nucleotidase/UDP-sugar hydrolase
MKQNYAKIISGFILAGLLTFSSCQSTHEMAKTDYQIAKVEGRMIDIDAKW
DTHPDADAVAILKPYKEKIDNMMYEVIGSSEQKMDKGHPESLLSNLVAEV
LRQAATKVQDKPADMGLVNMGGLRNILPAGDITVGTVYEILPFENSLCVM
KMKGTHLKALLTSIASLKGEGVSGIRMEITKDGKLLNATVGGQPIDDNKL
YTVATIDYLADGNGSMEAFLQADDRVCPEGATLRGLFLDYVRQQTAAGKK
ITSALDGRITVK
>BF1031 putative hypoxanthine guanine phosphoribosyltransferase
MDTIQIKDKLFTVSIREQEIQKEVIRVANEINRDLAGKNPLFLSVLNGSF
MFTADLLKHITIPCEISFVKLASYQGVSSTGSIKEVIGINEDIAGRTIVI
VEDIVDTGLTMQRLLETLGTRGPKEIHIASLLVKPDKLKVDLNIEYVAMN
IPNDFIVGYGLDYDGFGRNYPDIYTVVD
>BF1752 conserved hypothetical protein
MELTLNLNSRLQPMHRHDLEDALQEILEKINLGEVMGGGTLQNPQTGEIE
SCDIEIHLNDDKQDSINRLVELVNKIGIPKGSALLCMVPEFKIEVGTLEG
LAYYGNGTELPDEVYESCDINHVIEQMTSAMENIGSFYSYWEGNEWTALY
FYGTSFVEMKQKIEPFIASYPLCQKCRIEQIA
>BF0833 possible phosphoribosylformylglycinamidine cyclo-ligase
MSNQRYMMRGVSASKEDVHNAIKNIDKGIFPQAFCKIIPDILGGDPEYCN
IMHADGAGTKSSLAYMYWKETGDLSVWKGIAQDALIMNIDDLLCVGAVDN
ILVSSTIGRNKLLIPGEVISAIINGTDELLAELREMGVGVYATGGETADV
GDLVRTIIVDSTVTCRMKRADIINNANIRPGDVIVGLASHGQATYEKEYN
GGMGSNGLTSARHDVFAKYLAEKYPESYDAAVPEELVYSGGLKLTDTVEG
SPIDAGKLVLSPTRTYAPVVKKLLDALRPEIHGMVHCSGGAQTKVLHFVG
DVRVVKDNLFPVPPLFRTIQEQSGTDWAEMYKVFNMGHRLEVYLSPEHAA
EVIAISDSFGIPAQIVGRIEESDKKELIIKSEFGEFRY
>BF3554 putative lipoprotein
MKRYKKYMFIILSVLLAGGCVQEDINEALRREAELNVRMGKLREWISDTN
NEVRLLATIVNTIPTHDYIESVTELPDGSGTLIVFHKGGDILIKNGLTGN
KGENGNDGANGENGSDGANGTDGTDGKDGVDGQNGADGQNGSNGTDGTDG
HNGSDGQDGVNGEDGKDGVDGNDGKDGVKGPAGDTPLLGAKRDTDGNYYW
TVQIGGGAVEWLTDGEGNKVIMTPVNGVTPSVGIAKDTDGEYYWQVTVGG
VTKWITGGSGEKIVATVTDGSPSIFASVNTGNPEYVVFTMTDGSIYKVAK
TGDSKLIFNETGPLFFHRGVTQDVTFDCSSFRQIVKVAGTWDATINYQPK
ALQGTLTVKAPAAGSTLPASERITIEGTDALGNTVRADILVTLYYRIELP
KFNSSLVYDVLMEGVKVGEICREYVPAYSTTDRATVVYSYNAASRTFGSG
LILENGASIQHDGTGYMPVAGNPSSTAILTEDGSRYVMAADGADGLVSGT
VCGLKASLAVDVQGYAYRVVKIGSLYWMGENLKTTQFNDGTPIPTGFATS
LDWGIQCGKGFPACQVDRAVNANAPGAMQYRNLYGVLYNQFAMKGNIAPQ
GWHVPSKAELQALVDFVGADARKLKSTAVGKGIGNWLEDTGIEANNLTGF
TALPANTVDGGNGSTGAQETTGQWWSTETSYRIRMSYKSNSVELLTSGNA
LAGEGNSIRCVRDANY
>BF3619 putative ribonucleoside reductase
MIYQKTFIALQARLLMISKLLHIYLLIKKSKTHCIVEKQIYSYEEAFEES
LRYFQGDELAARVWVNKYAVKDSFGNIYEKSPKDMHWRLANEVARIEAKY
PNALSSEQLFELFDHFKYIVPQGSPMTGIGNDYQVASLSNCFVIGIDGSA
DSYGAIIKIDEEQVQLMKRRGGVGHDLSHIRPKGSPVKNSALTSTGLVPF
MERYSNSTREVAQDGRRGALMLSVSIKHPDSEAFIDAKMTEGKVTGANVS
VKLDDAFMSAAVEGRKYTQQYPIDSDHPTTVKEIEASNLWKKIVHNAWKS
AEPGVLFWDTIIRESVPDCYADLGYKTVSTNPCGEIPLCPYDSCRLLAIN
LYSYVVNPFTKDAYFDFDLFHKHVALAQRIMDDIIDLELEKIERIIEKID
QDPENEEVKHTERGLWEKIYKKSGQGRRTGVGITAEGDMLAALGMRYGTE
EATEFSEKVHKAVALGAYRSSVDMAKERGAFDVYDSEREKNNPFINRLRE
ADPALYEDMKKYGRRNIACLTIAPTGTTSLMTQTTSGIEPVFLPVYKRRR
KVNPNDTNVRVDFVDETGDAFEEYIVFHHKFVTWMEANGYDPAKRYTQEE
IDELVAKSPYYKATSNDVDWLMKVRMQGKIQKWVDHSISVTINLPNDVDE
ELVNRLYVEAWKSGCKGCTVYRDGSRSGVLISAKSDKDKKEELPPCKPPT
VVEVRPTVLEADVVRFQNNKEKWVALVGLLDGRPYEIFTGLQDDDEGIII
PKSVNTGRIIKNVDENGNKRYDFQFENKRGYKMTIEGLSEKFNKEYWNYA
KLISGVLRWRMPIEQVIKLVGSLQLDSENINTWKNGVERALKKYVQDGTE
AKGKKCPNCGNETLVYQEGCLICTTCGASRCG
>BF3484 putative anaerobic ribonucleoside-triphosphate reductase
MNYAEICIIKRDGKREDFSISKIKNAVSKAFSATGINDEQQLIADITMNV
IGQFASPTITVEEIQDLVEKELMKVRPEVAKKYIIYREWRNTERDKKTQM
KHVMDGIVAIDKNDVNLSNANMSSHTPAGQMMTFASEVTKDYTYKYLLPK
RFAEAHQLGDIHIHDLDYYPTKTTTCIQYDMDDLFERGFRTKNGSIRTPQ
SIQSYATLATIIFQTNQNEQHGGQAIPAFDFFMAKGVSKSFRKHLASFIS
FYVQMNKGEEIEEKAIRTVIAEHLSSIKASELERETLRMALTALQINIDK
EHLNQIIEKAFVQTQKDTHQAMEGFIHNLNTMHSRGGNQVVFSSINYGTD
TSAEGRMVIEELLKATVEGLGTRGEVPVFPIQIFKIKNGVSYTEADYEKA
MANFDAAMEGKLKFEAPNFDLFLKACHTTAKALFPNFMFLDAPFNQNEKW
DANDPQRYRYELATMGCRTRVFENVAGEKSSLGRGNLSFTTLNMPRLAIE
ARIKAENMTEDGHNKDAVERKAKEIFIESIHETATLIAEQLYERYQYQRT
ALARQFPFMMGNDVWKGGAALNPNEQVGDVLRSGTLGIGFLGGHNAMVAL
YGEGHGHSQKAWDTLYEAVLEINKVADEYKAKYNLNYSVLATPAEGLSGR
FTRMDRRKYGKIKGVTDNDYYVNSFHVDVKEPISIVEKIKREAPFHAITR
GGHITYVELDGEAQKNVRAIAKIVKVMFDEGIGYGSINHPVDTCHNCGYK
GVIYDKCPVCQSENILRMRRITGYLTGDLSSWNSAKRAEEKDRVKHG
>BF1645 putative nucleotide deaminase
MTKEELMRKAIELSRENVANGGGPFGAVIAKDGEIVATGVNRVTASCDPT
AHAEVSAIRAAASKLGTFNLSGYEIYTSCEPCPMCLGAIYWARLDKMYYG
NNKTDAKNIGFDDSFIYDELELKPENRKLPSEVLLHDEAIKAFEEWMEKE
DKIEY
>BF1699 putative xanthine phosphoribosyltransferase
MQLLKKRILQDGKCYEGGILKVDSFINHQMDPVLMKSIGVEFVRLFAGTN
VNKIMTIEASGIAPAIMTGYLMDLPVVFAKKKSPRTIQNALSTTVHSFTK
DRDYEVVISSDFLTPKDNVLFVDDFLAYGNAALGVIDLIKQSGANLVGMG
FIIEKAFQNGRKTLEERGVRVESLAIIEDLSNCRITIKD
>BF0626 putative uridylate kinase
MAKYKRVLLKLSGESLMGEKQYGIDEKRLAEYAAQIKEIHEQGVQIGIVI
GGGNIFRGLSGANKGFDRVKGDQMGMLATVINSLALSSALVAAGVKARVL
TAVRMEPIGEFYSKWKAIECMENGEIVIMSAGTGNPFFTTDTGSSLRGIE
IEADVMLKGTRVDGIYTADPEKDPTATKFHDITYDEVLKRGLKVMDLTAT
CMCKENNLPIVVFDMDTVGNLKKVITGEEIGTLVHN
>BF0515 possible secreted 5'-nucleotidase
MIFPINKKHTFFSKEKTLLTFFFILFISFSAFGQQDKKLILLQTSDVHSR
LEPINQEGDRNYDKGGFVRRATFVKEFRKEHPDMLLFDCGDISQGTPYYN
MFQGEVEVKMMNEMKYDAMTIGNHEFDFDLDNMARLFRMADFPVVCANYD
VSATVLKDLVKPYVVFERDGVKIGVLGLGCQLEGMVQANKCVGVVYNDPV
TVANEVAAVLKEKEGCDVVVCLSHLGVQYDENQLIPKTRNIDVVLGGHSH
TFMKGPKTLLNMDGKNVSLMHTGKSGIYVGQMDLTLEKKK
>BF1704 putative endonuclease
MKNKRKRPSKKQHHNSFKSFWIIALFAILPLIYGVYLCTPEIQAVFFQAT
KVSRPNVARPNYSHDENLKVPVSQFPLTEQIIHHKGYTVSYNKDKKIPNW
VAYELTKQKTQGNIKRNERFIADPVVKGGMANNSDYSRSGFDKGHMAPAA
DMKWSNEAMKESFYFSNVCPQHPELNRRKWKTLEDKVREWAVADSAILII
CGPVTNKKSPVIGKSRVTVPSKFFKVILSLHGSTPKAIGFIFKNERAIAP
LRNYAVSIDSIEQLTGLDFFSSLPDSLENEIESRIDTTLWSI
>BF0831 putative orotidine 5'-phosphate decarboxylase
MNKQSLFENIKRKKSFLCVGLDTDIKKIPDHLLDDPDPIFAFNKAIVDAT
ADYCIAYKPNLAFYESMGVKGWIAFEKTVNYIKENYPDQFIIADAKRGDI
GNTSAMYARTFFEELDIDSVTVAPYMGEDSVTPFLSYEGKWVILLALTSN
KGSHDFQLTEDANGERLFEKVLKKSQEWANDEQMMYVVGATQGRAFEDIR
KIVPNHFLLVPGIGAQGGSLEEVCKYGMNSTCGLIVNSSRGIIYVDKTEN
FAAAARAAAKEVQEQMAEQLKAIL
>BF2939 putative lipoprotein
MKKHLILMISAAIIPLLLYACSAEEERALTSTTLEVAQSAIDFKSDAGTR
DIAIVTNADHWTARSDKDWCSVAVNESTLTVNVSGYDGKETREAVIKVTA
DGLAETVNVRQLGSEPAILISQQIFTVEASGSDIAFDVTTNVSVTITLPE
WIKEKPAGTRASEMVTTTHNYIVTANPEDSERTGNITVKEVGGELEALVS
VTQKGLGEYESGNLEGIKDDIKVPVESGEASSFQGGSNIDKSFDGDMSTI
YHSNWNNAGDHYFPITLTYNFAAGSDMDYLIYYPRTSGPNGNFKEVEIRV
KSNANTRGTDEWNTVMTKNFGGTNAAVRVNFPKAQIGVTSVQFIVKSGSG
DGQGFAACAEMEFYKKNPDAFDPLTLFTDGTCSELKPGLTDEEIENCPYS
FYKNIAYYMKQGKYPAEFRIQEYKAWPHPDAQSETHKTSPYSLRDNPTGI
SVKDGEQLMIFVGDTHGQTVSAVIQNLDVPGGDGFGGTSYPLSEGANKIT
ARNKGLMYILYHTPDYETAQPVKIHIASGQVNGYFDVAKHQASDWNKLLS
NAVDKYFDVVGHYAHLTFPTERFRTHTPDGKALIDAYDQIVNSEMELMGL
YKYNKLFKNRMYLHVMYTSYMYATSYHTAYNDGTLAELCNVDKLKTSACW
GPAHEIGHCNQTRPGLKWLGTTEVTNNIMSEYIQTTIFGQPSRLQTEDMG
DGSRNRYSKAWTQIIAAGAPHGNFGSDSDVFCKLVPFWQLELYFGKVLGR
TPLQQSDKGGFYPDVYEYIRTHDNLRTAGEQQTEFVYICSLIAKANLLDF
FTKWGFLTPVDITVDDYGTGKLTVTQARIDEIRSRVEALGYPKPDVALEY
ITDNSVELYKDKPGIVAGTATRSGSTFTMTNWKNVAAYEVVDETGKKVCI
SDGLLAPSGTATFTMKTAWKDGFKVYAVSATGARTAVTF
>BF2688 putative IMP cyclohydrolase
MTNELELKYGCNPNQKPARIFIKEGELPIEVLNGRPGYINLLDALNSWQL
VKELKEATGLPAAASFKHVSPAGAAVAVEMNDTLKKIYFVDDMELSPMAT
AYARARGADRMSSYGDFIALSDICDEPTARIINREVSDGVIAPGYTPEAL
EILRNKRKGTYNVIKIDPAYRPAPIEHKDVFGITFEQGRNELKIDESLLK
EMPTRNRIIPADAQRDLIIALITLKYTQSNSVCYAKDGQAIGIGAGQQSR
IHCTRLAGNKADIWYLRQHPKVMNLPWKEKIRRADRDNTIDVYISDDYMD
VLADGVWEQFFTRKPEVLTREEKRAWLDTQSGVALGSDAFFPFGDNIERA
YKSGVSYIAQPGGSVRDDHVIETCDKYDIAMAFTGIRLFHH
>BF4126 putative Hit-family protein
MATIFSRIIAGEIPCYKVAENEKFFAFLDINPLVKGHTLVVPKQEVDYIF
DLSDEDLAAMHVFAKKIARAIEKAFPCKKVGEAVIGLEVPHAHIHLIPIQ
KESDMLFSNPKLKLADDEFVSIAKAISSAYETAK
>BF4374 putative Ham1-like protein
MKRKLVFATNNAHKLEEVSAILGDKVELLSLNDINCHTDIPETAETLEGN
AYLKSSFIYRNYGLNCFADDTGLEVESLGGAPGIYSARYAGGEGHNAEAN
MLKLLHELEGKDNRRAQFRTAISLILDEKEYLFEGIIKGEIIKEKRGDSG
FGYDPVFVPEGYDRTFAELGNEIKNQISHRALAVNKLCEFLRSI
>BF2965 putative allantoinase
MKRTLIQNATIVNEGRSVRGSVVIEGEKIAEVLEKGQKPAIPCEETINAN
GCYLIPGVIDDHVHFRDPGLTHKADISTESRAAAAGGVTSIMDMPNTNPQ
TTTLDALNAKFDLLAEKCSVNYSCYFGATNNNYTEFDKLDKNRVCGIKLF
MGSSTGNMLVDKMNSLLNIFNGTDLLIAAHCENHETIKKNTEKYVKEYIE
KYPHQYYHVHHETLPMGYHAKIRSIAACYESSELAVRLARIADARLHILH
ISTARELSLFDNDIPLEEKRITAEACVSHLLFDSSDYPELGARIKCNPSI
KTKTNRDALRQAVNSNLIDVIATDHAPHLLKEKEGGPLKAMSGMPMIQFS
LVSMLELVNEGIFTIEKVVEKMCHAPAQIYNIHNRGFIRPGYQADLVLVR
PDALWTVSADQILSKCGWSPLEGRTFEWKVEKTFANGHLLYTDGQVDETY
RGQEIYFER
>BF2826 putative dihydroorotate dehydrogenase
MADLKTTFAGLTLKNPVIISSSGLTNSAAKNAKLEAAGAGAIVLKSLFEE
QIMMEADRLRNPSYYPEGSDYLAEYIRNHKLAEYLELIKESKKICTIPVI
ASINCYTDAEWVDFAKQIEEAGADALEINILALQSDIQYKYGSFEQRHID
ILSHIKKTIRIPVIMKLGSNFTNPVALIDQLYANGAAAVVLFNRFYQPDI
DVEKMEHTSGDVFSNASDLSTTLRWIGISSSLVSKIDYAASGGIHKPDGI
VKAILAGASAIEICSAIYQNTNLFVGEMNRFLSAWMERKGFKHISQFKGK
LNAKDVGGINMFERTQFLKYFSEK
>BF2203 putative uracil permease
MDSNHLSPLRKGVVGVQFLFVAFGATVLVPLLVGLDPSTALFTAGISTLL
FHLVTKGKVPIFLGSSFAFIAPIIKATELYGLAGTLSGMVGVAMVYFVMS
ALVKWQGIRLIERLFPPVVIGPVIILIGLSLAGTGVNMAKENWTLALLSL
FTAVIVSIRAKGLLKLIPIFCGIIMGYIAALIFYDVDMSGVRNAAWLGFP
QFVFPQFSWEPILFMMPVAIAPVIEHIGDVYVVNTVTGKDYVKDPGLHRT
LLGDGLACLCAGLLGGPPVTTYSEVTGAMSLTKVTNPQVIRIAAITAILF
SVIGKVSALLKSIPSAVLGGIMLLLFGTIACAGIANLVNNCIDLSRTRNI
IIVSLTLTIGIGGAVLAWGEFSLSGIGLAALVGVGLNLVLPREER
>BF4243 putative uracil phosphoribosyltransferase
MKIINLSETDSILNQYVSEIRNVEVQNDRLRFRRNIERIGEVMAYEMSKT
FAYSVKEIQTPLGIAPVRTPDNPLVISTILRAGLPFHQGFLSYFDYAENA
FVSAYRKYKDTLKFDIHIEYIASPRIDGKTLIITDPMLATGGSMELSYQA
MLTKGHPSEIHVASIIASQRAVDHIASILPEDKTTIWCAAIDPEINEHSY
IVPGLGDAGDLAFGEKE
>BF2669 putative phosphatase
MKKVNYAAIDIGSNAVRLLIKSVNEEGSPEGLLRKVQLIRIPLRLGEDAF
TTGEISEGKAEKLIRLMKAYKQLMKIFEVSDYRACATSAMRDARNGKEIT
RKIEKKTGIRVEIIDGQEEAHIVYDNHIEQLFASGQNYLYVDVGGGSTEI
NLICDSELKSSRSYNIGTVRMLSGMVKNEEKEQMRTDLQALAAEYAPIQI
IGSGGNINKLFRLADKKDKKQSFLPIESLKEICETLKALSKEERIKQFKL
KPDRADVIVPAAEIFLEVAKQVNATGITVPTIGLSDGIIDSLYTKNMRME
TDAK
>BF3401 conserved hypothetical protein
MLKILVTYAVQGEFTEIKWPDVEVYYVRTGIGKVKSAFHLSEAIQQVKPD
IVINQGTAGTINHQVGDVFVCRHFVDRDMHKMTGLGMEYRIDSSELLAAK
GFCQHWTESATCNTGDSFLTELTDIEGDVVDMEAYAQAFVCRAKEIPFIS
VKYVSDVIGQNSVKHWEDRLEDARAGLSHFFNVLKESI
>BF0108 putative deoxyribose-phosphate aldolase
MNDTPQDKYLTALAKYDTQLNDADVQVQVAALIEKKVPENNTEEVKKFLF
NCIDLTTLNTTDSDESVMRFTEKVNRFDDEFPDLKNVAAICVYPNFAQVV
KDTLEVEGINIACVSGGFPSSQTFTEVKIAETAMALADGADEIDIVIPVG
AFLSGDYETMCEEIMELKETCKEHHLKVILETGALKTASNIKKASILSMY
SGADFIKTSTGKQQPAATPEAAYVMCQAIKEYYEQTGNKVGFKPAGGINT
VNDALIYYTIVKEVLGKEWLSNELFRLGTSRLANLLLSEIKGEELKFF
>BF2714 putative ribonucleoside-diphosphate reductase beta chain
METKKLKKNALFNPEGDTETRFRKMIGGNTTNLNDFNNMRYQWVSDWYRQ
AMNNFWIPEEINLTQDTKDYPHLTPAERTAYDKILSFLVFLDSLQSNNLP
TLSEYITANEVNLCLHIQAFQECVHSQSYSYMLDSICSPEERNDILYQWK
TDEHLLRRNTFIGNCYNEFQENRDGFALMKTLIANYILEGIYFYSGFMFF
YNLSRNGKMSGSAQEIRYINRDENTHLWLFRNIILELKKEEPELFTPDKV
KVYEEMMREGVKQEIAWGQYVIGDQIQGLNRQMISDYIHFLGNLRWSSLG
YTPLYEDNRKEPESMHWVSQYSNANMVKTDFFEAKSTAYAKSTALEDDL
>BF0882 putative deoxycytidylate deaminase
MDTANSKQSDLDKRYIRMASIWSENSYCQRRKVGALIVKDKMIISDGYNG
TPSGFENVCEDDNNVTKPYVLHAEANAITKIARSNNSSDGATMYVTASPC
IECAKLIIQAGIKRVVYSEHYRLEDGIELLKRAGIEVVFVDTSEK
>BF0637 possible cytosine deaminase
MLDDSYFMKQALIEAVKAGERGEVPVGAVVVCKERIIARAHNLTETLNDV
TAHAEMQAITAAANVLGGKYLNECTLYVTVEPCVMCAGAIAWAQTGKLVF
GAEDDKRGYQRYAPQALHPKTVVVKGILADECAGLMKDFFAAKRR
>BF3154 putative phosphoribosylformylglycinamidine synthase
MLIFARKENKIVYTHMILFFRTPSKSVIAVESNHELNANDNNKLCWLFGE
AMPESEENLQGCFVGPRREMITPWSTNAVEITQNMGLDGISRIEEYFPVK
DENADHDPMLQRMYKGLNQNVFTTNRQPEAIIYIDDLEAYNEKEGLALSK
EEMDYLKKVESDLGRRLTDSEVFGFAQINSEHCRHKIFGGTFIIDGVEQE
SSLFQMIKKTTQENPNKIISAYKDNVAFAEGPVVEQFAPADHSKPDFFRI
KDIKSVISLKAETHNFPTTVEPFNGASTGTGGEIRDRMGGGKGSWPIAGT
AVYMTSYPRTEEGREWEDILPVRKWLYQTPEQILIKASNGASDFGNKFGQ
PLICGSVLTFEHTENNETYAYDKVIMLAGGVGYGTQRDCLKGQPEAGNKV
VVIGGDNYRIGLGGGSVSSVDTGRYSSGIELNAVQRANAEMQKRANNVVR
ALCEEDENPVVSIHDHGSAGHVNCLSELVEECGGLIDMSKLPIGDKTLSA
KEIIANESQERMGLLIKEEAIEHVRQIAERERAPMYVVGETTGDHRFAFQ
QADGVRPFDLAVDQMFGSSPKTYMIDKTVERHYTMPEYETSKLHEYLTQV
LQLEAVACKDWLTNKVDRSVTGKVARQQCQGEIQLPLSDCGVVALDYRGE
KGIATSIGHAPQAALADPAAGSILSVSEALTNLVWAPLAEGLDSVSLSAN
WMWPCRSQEGEDARLYTAVKALSDFCCALQINVPTGKDSLSMTQKYPNGE
KVVSPGTVIVSAGGEVSDIKKVVSPVLVNDAKTTLYHIDFSFDNLKLGGS
AFAQSLGKVGSEVPCVQDAEYFRDAFLAVQELVNKGLILAGHDISAGGLI
TTLLEMCFANVEGGLEISLDKMKETDIVKILFAENPGIVIQISDKHKDEV
KKILEDAGVGFIKLGKPTDERHILVNKEGATYQFGIDYMRDVWYSSSYLL
DRKQSMNGCAKKRFENYKMQPLEFAFMPGFKGKLSQYGITPERRTPSGIR
AAIIREKGTNGEREMAYSLYLAGFDVKDVTMTDLISGRETLEDVNMIVYC
GGFSNSDVLGSAKGWAGGFLFNPKAKEALDKFYAREDTLSLGICNGCQLM
MELGLVNPEHEKKGKMLHNESHKFESTFVGVTIPTNRSVMFGSLSGSKLG
IWVAHGEGKFSLPYDEDQYNVVAKYSYDEYPGNPNGSDYSIAALASADGR
HLAMMPHLERAIFPWQNACYPADRVHNDQVTPWIEAFVNARKWVEEKKK
>BF2822 putative nucleotidase
MEKLHIRKIASLGLMLCFFTGGGAQTPVKVEKRKEHKSNTVIPVVKGNVT
DTLSLVSFNDFHGAFACDKGVPGAGQLVQTVLTQKEKNKNTIVLSVGDNF
SGSYFSRITRGNPLPEMFQEMDVRMSAVGNHEFDWGLPYLTDTAKVYMNF
VAANIITDRGDTLEWAKPYRIVTLNLKNGGTVRVAFVGLTTTDTAHKTSP
ENIKGLAFVHPVYAARVETACRLKKEGKVDMVVLLMHIGTNMKNRDIIEE
ENAKLLPFLKGVDAIISGHSHEVVLSKVNDVPIIQAGVNGTHIGKLDFRV
VKEEGGNRISYIGGDTIRTEGPSNAHIDSLVDKVLAVYGLSEKLILAKDA
LIHDRTINKWEYTPVGAYVTAAYVRSFLENEKVPAELKVLPVIGVNHFGG
LRASIPAGEVTRLRAGNVLPFGGNVVAYEFTGERLKQLLDDGRRNKNGFL
QTSYLKLHLNSKGNVETITDCRTNKIIRDDDKCIVVLDAFITSGGDGYDS
KLFSGYEIGDFNSQNLETTVAFIDYLKSLKGFVSSEAAPIPIVQK
>BF1142 putative purine nucleoside phosphorylase/uridine phosphorylase family protein
MKKYFPSSELIINEDGSVFHLHVKPEWLADKVILVGDPGRVALVASHFEN
KECEVESREFKTVTGTYKGKRITVVSTGIGCDNIDIVVNELDALANIDFQ
TREEKEHLRSLELVRIGTCGGLQPNTPVGTFVCSEKSIGFDGLLNFYAGR
NAVCDLPFERAFLNHMGWSGNMCAPAPYVIDANAELIDRIAQEDMVRGVT
IAAGGFFGPQGRELRVPLADPKQNDKIEKFEYKGYKITNFEMESSALAGL
SKLMGHKAMTVCMVIANRLIKEANTGYKNTIDTLIKTILDRI
>BF3733 putative nucleoside diphosphate kinase
MMEKTLVILKPCTLQRGLVGEITRRFERKGLRLAGMKMVQLTDEVLSEHY
SHLSSKPFFQRVKDSMMTAPVIVCCFEGVDAIQAVRALAGPTNGRLAAPG
TIRGDYSMSFQENIVHTSDSPETAAVELNRFFKPEEIFDYKQATFDYLYA
NDEY
>BF2713 putative ribonucleoside-diphosphate reductase alpha chain
MEITKRNGTTEPYDREKIAVAIRKSFASTGQEVSNEIIYSVVEEVENFVG
KDTANRSVEQIQDKVEQSLMEHGFYAEAKNYILYRWQRTERRKALNSIIN
ELGDGTVMDVLKEIQKDFTTHEYSLVVLYEKFSGFCKQEMPHSERLAALI
KAAVELTTQEAPDWEFIAARLLNFQLSKKLEKQAASAGIRSFYDKLRYLT
EEGLYGSYILAAYSQQEIEEAAGFICPDRDKLFNYSGLDLLVKRYLIRTR
LHEPAESVQEMYLGIALHLAMPEQKERMTWVKKFYDLLSRLEVTMATPTL
SNARKPYHQLSSCFIDTVPDSLEGIYRSIDNFAMVSKFGGGMGMYFGKVR
AAGGNIRGFKGVAGGVIRWMKLVNDTAVAVDQLGMRQGAVAVYLDVWHKD
LPEFLQLRTNNGDDRMKAHDIFPSVCYPDLFWKMAKEDLNQPWYLFCPNE
IMTIKGYCLEDYYGEEWEKRYHDCVNDTRLSKRSISIKDIVRLVLRSAVE
TGTPFTFNRDTVNRANPNAHRGIIYCSNLCTEIAQNMAAIETVSTEIRTE
EGDTVVVKTVRPGDFVVCNLASLSLGHLPLEDEEQIKEKVSTVVRALDNV
IDLNFYPLPFAQITNQRYRSIGLGVSGYHHALAIRNIRWESEEHLRFVDR
VFEQINYAAIEASADLAKEKGRYEYFEGSDWQTGAYFGKRGYTSPEWNRL
AAKVAENGMRNAYLLAIAPTSSTSIIAGTTAGTDPVMKRFFLEEKKGAML
PRVAPALSDKTFWLYKDAYTLDQKWSIRAAGTRQLHIDQSQSLNLYITNE
FTMRQVLDLYLLAWECGVKTVYYVRSKSLEVEECESCAS
>BF2479 putative AMP nucleosidase
MKTKQEIVANWLPRYTKRNLEDFGEYILLTNFNKYVEIFAEKFNVPILGK
DANMISASAEGITIINFGMGSPNAAIIMDLLSAISPKACLFLGKCGGIDK
KNKIGDLILPIAAIRGEGTSNDYFPPEVPSLPAFMLQRAVSSAIRDYARD
YWTGTVYTTNRRIWEHDDTFKEYLKRTRAMAVDMETATLFSCGFANHIPT
GALLLVSDQPMIPEGVKTDKSDNIVTKNYVEEHVEIGIASLRMIIDEKKT
VKHLKFDW
>BF1873 putative 2', 3'-cyclic nucleotide 2'-phosphodiesterase
MIMMKRLICMYAFLLCLVCVLPAQEREVKLKIVQTSDVHGNYFPYNFITQ
KEWGGSLARVYALVQKNREVYKENLILLDNGDILQGQPSAYYYNYIDTVA
PHVCAEMMNFMGYDAGNMGNHDVETGRAVFDRWIGECNFPVLGANIVETA
TGETHLPPYRVLERDGVKIVVLGMITPAIPAWLSENLWQGLRFDDMEETA
RKWMKVIREKENPDLVIGLFHAGQDAFVMSGKYNENASLNVAKNVPGFDM
VLMGHDHARECKKVVNVAGDSVLVIDPASNGIVVSDIDVTLKLKDGKVVS
KQIDGVLTDTKEYGVSESFMRHFALQYGAVEKFVSKKIGVFTEDLSTRPA
YFGSSAFIDFIHSLQLDISGADISFAAPLSFDAEIKKGDIRVSDMFNLYK
YENMLYVMKLSGKEIKDFLEESYYMWTNRMKSPEDHLLWLKEKRRAGAED
RASFQNFSFNFDSAAGIIYTVDVTRPKGEKVTIVSMADGSPFRMDHIYKV
ALNSYRGNGGGELLTKGSGIPQEKLKERIIFSTDKDLRFYLMQYIEKKGT
LDPRALNQWKFVPEEWVKPAAERDYEYLFGGK
>BF1032 putative adenylate kinase
MLNIVIFGAPGSGKGTQSERIVEKYGINHISTGDVLRAEIKNGTELGKTA
KGYIDQGQLIPDELMVDILASVFDSFKDSKGVIFDGFPRTIPQAEALKVM
LKERGQDISVMLDLDVPEEELMTRLIKRGKESGRADDNEETIKKRLVVYN
TQTSPLKEYYKGEGKYQHINGLGTMEGIFEDICKAVDTL
>BF0840 putative succinoaminoimidazolecarboximide ribonucleotide (SAICAR) synthetase
MKALTKTDFNFPGQKSVYHGKVRDVYNINGEQLVMVATDRISAFDVVLPE
GIPYKGQMLNQIAAKFLDATTDICPNWKLATPDPMVTVGVLCEGFPVEMI
VRGYLCGSAWRAYKNGVREICGVKLPEGMKENQKFPEPIVTPTTKAEMGL
HDEDISKEEILAQGLATPEEYAILEKYTLALFKRGTEIAAERGLILVDTK
YEFGKHNGTIYLMDEIHTPDSSRYFYAEGYQERFEKGEAQKQLSKEFVRE
WLMENGFQGKEGQKVPEMTPAIVESISERYIELFENITGEKFVKEDTSNI
AERIEKNVMAFLAK
>BF4214 putative MutT/NUDIX family protein
MMEHPLNQFKYCPKCGSAAFEIHNEKSKQCTDCGFVYYFNPSSATVALIL
NEKDELLVCRRAKEPAKGTLDLPGGFIDMNETGEEGVSREVEEETGLKVK
KATYLFSLPNIYIYSGFPVHTLDMFFLCQVEDTSHFEAMDDVADSFFVPL
CQINPEEFGLGSIKKGLKRFLKER
>BF0112 apt, putative adenine phosphoribosyltransferase
MIMSKEKLIKSIREVPDFPIPGILFYDVTTLFKDSERLQELSDIMYEMYK
DKGITKVVGIESRGFIMGPILATRLGAGFIPIRKPGKLPAETMEESYDKE
YGKDTVQIHKDALNENDVVLLHDDLLATGGTMKAACNLVKKLHPKKVYVN
FIIELKELNGKQVFENDQDVDIQSVLSL
>BF2658 carA, putative carbamoyl-phosphate synthase small chain
MKNVTLILDDGSRFHGKSFGYEKPVAGEVVFNTAMTGYPESLTDPSYAGQ
LMTLTYPLVGNYGVPPFSIEPGGLATFMESERIHAEAIIVSDYSQEYSHW
NAVESLADWLKREQVPGITGIDTRELTKVLREHGVMMGRIVFDDEPESAP
EAVYSGVNYVDKVSCKEVIRYNEGADKKKVVLVDCGVKTNIIRCLLRRDV
AVIRVPWNYDFNHLKFDGLFISNGPGDPDTCDAAVQNIRKAMQNPKLPIF
GICMGNQLLSKAGGAKIYKLKYGHRSHNQPVRMVGTERCFITSQNHGYAV
DNNTLGTDWEPLFINMNDGSNEGIRHKTNPWFSAQFHPEAASGPTDTEFL
FDEFVKLL
>BF2657 carB1, putative carbamoyl-phosphate synthase large chain 1
MKENNIKKVLLLGSGALKIGEAGEFDYSGSQALKALKEEGIETILINPNI
ATVQTSEGVADQIYFLPVTPYFVEKVIRKERPESIMLAFGGQTALNCGVA
LYREGILEKYNVKVLGTPVQAIIDTEDRELFVDKLNEIDVKTIKSEAVEN
AEDARRAARELGYPVIVRAAYALGGLGSGFCDNEEELDLLVEKAFSFSPQ
VLVEKSLRGWKEVEYEVVRDRFDNCITVCNMENFDPLGIHTGESIVIAPS
QTLTNKEYHKLRELAIRIIRHIGIVGECNVQYAFDPESEDYRVIEVNARL
SRSSALASKATGYPLAFVAAKLGLGYGLFDLKNSVTKTTSAFFEPALDYV
VCKIPRWDLGKFHGVDKELGSSMKSVGEVMAIGRTFEEAIQKGLRMIGQG
MHGFVENKELVIPDIDKALHEPTDKRIFVISKAFRAGYTIDQVHELTKID
KWFLQKLMNIMNTSEELHQWGNNHKQIADLPADLLKQAKRQGFSDFQIAR
AIGYEGDMEDGSLYVRNYRKSLGIVPVVKQIDTLAAEYPAQTNYLYLTYS
GTANDVTYLGDHRSIVVLGSGAYRIGSSVEFDWCGVQALNTIRKEGWRSV
MINYNPETVSTDYDMCDRLYFDELTFERVMDVLELENPHGVIVSTGGQIP
NNLALRLDAQNIHILGTSAQSIDNAEDRDKFSAMLDRIGVDQPEWRALTS
LEDINSFVDKVGFPVLVRPSYVLSGAAMNVCSNQEELERFLQLAANVSKK
HPVVVSQFIEHAKEVEMDAVAQNGEIIAYAISEHIEFAGVHSGDATIQFP
PQKLYVETVRRIKRISREIAKALNISGPFNIQYLAKDNDIKVIECNLRAS
RSFPFVSKVLKINFIELATKVMLGLPVEKPEKNLFELDYVGIKASQFSFN
RLQKADPVLGVDMASTGEVGCIGSDTSCAVLKAMLSVGYRIPKKKILLST
GTPKQKVDMLEAARMLQKKGYDIFATGGSSKFLTENGVENTRVYWPSEEG
HPQALEMLHKKEIDMVVNIPKNLTAGELDNGYKIRRAAIDLNIPLITNAR
LASAFINAFCTMDIDDIAIKSWEEYK
>BF3808 carB2, putative carbamoyl-phosphate synthase large chain 2
MEKEMKKVLVLGSGALKIGQAGEFDYSGSQALKALKEEGINSVLVNPNIA
TIQTSEGIADKVYFLPVTTYFVEEIIKKERPDGILLAFGGQTALNCGAEL
YTKGILDKYGVKVLGTSVEAIMYTEDRDLFVKKLDEIEMKTPISQAVESM
EDAIAAARRIGYPVMVRSAYALGGLGSGICANEEEFLKLAESSFAFSKQI
LVEESLKGWKEIEFEVIRDANDHCFTVASMENFDPLGIHTGESIVVAPTC
SLDDKELKMLQELSTKCIRHLGIVGECNIQYAFNSDTDDYRVIEVNARLS
RSSALASKATGYPLAFVAAKVALGYTLDQIGEMGTPNSAYVAPQLDYYIC
KIPRWDLTKFAGVSREIGSSMKSVGEIMSIGRSFEEIIQKGLRMIGQGMH
GFVGNDDVHFEDLDKELSHPTDLRIFALAQAMEEGYTIERIHELTKIDPW
FLGKLKNIVDYKAKLSAYDKVEDIPADVLREAKVLGFSDFQIARFVLNPV
GNMEKENLMVRARRKELGILPAVKRINTIASEHPELTNYLYMTYAVQGYD
VNYYKNEKSVVVLGSGAYRIGSSVEFDWCSVNAVQTARKLGYKSIMINYN
PETVSTDYDMCDRLYFDELSFERVLDVIDLEQPRGVIVSVGGQIPNNLAM
KLYRQSVPVLGTSPISIDRAENRNKFSAMLDQLGIDQPAWQELTSLEDVK
GFVEKVGYPVLVRPSYVLSGAAMNVCYDDEELENFLKMAAEVSKEYPVVV
SQFLENTKEIEFDAVAQNGEVVEYAISEHIEFAGVHSGDATLVFPAQKIY
FATARRIKKISRQIAKELNISGPFNIQFLARNNEVKVIECNLRASRSFPF
VSKVLKRNFIETATRIMLDAPYSRPDKSAFDIDWIGVKASQFSFSRLHKA
DPVLGVDMSSTGEVGCIGDDFSEALLNAMIATGFKIPGKGVMFSSGAMKS
KVDLLEASRMLFNQGYKIYATAGTAAFLNAHGVDTTPVYWPDEKPGAENN
VMKMIADHKFDLIVNIPKNHSKRELTNGYRIRRGAIDHNIPLITNARLAS
AFIEAFCDLKLEDIQIKSWQEYK
>BF1427 cdd, putative cytidine deaminase
MDDAIEATRRSYAPYSHFSVGAAALLANGVVVTGTNQENAAYPSGLCAER
TTLFYANSQYPDQAVVTLAIAARTEKDFIDTPIPPCGACRQVILETEKRY
KQPIRILLYGKKCIYEVQSIGHLLPLSFDASAMED
>BF3535 cmk, putative cytidylate kinase
MKKITIAIDGFSSCGKSTMAKDLAKEIGYIYIDSGAMYRAVTLYSIENGI
FHGDTIDTDELKRRIGDIHISFRIDPETGRPNTYLNGVNVENKIRTMEVS
SKVSPISALGFVREAMVAQQQEMGKAKGIVMDGRDIGTTVFPDAELKIFV
TASAEIRAQRRYDELKAKGQETGFEEILENVKQRDHIDQTREVSPLKKAD
DALLLDNSHLTIAEQKEWLMAEYQKAIKA
>BF0271 dgt, putative deoxyguanosinetriphosphate triphosphohydrolase
MMDWKRLISAKRFGMEEFHEERQENRSEFQRDYDRLVFSAPFRRLQNKTQ
VFPLPGSIFVHNRLTHSLEVSCVGRSLGNDVSKAILARQPELQDSFLPEI
GSIVSAACLAHDLGNPPFGHSGEKAISTFFSEGKGAQLQEKLSPMEWNDL
THFEGNANAFRLLTHQFEGRRKGGFVLTYSTLASIVKYPFSSSLAGNKSK
FGFFTTEEEGFRRIATELGLIQLSDRPLKYARHPLVYLVEAADDICYQMM
DIEDAHKLKILTTEETKELLLAYFADERQTHIRKTFDIVKDTNEQIAYLR
SSVIGLLIKECTQVFLNNETEILSGTFEGALIKHISERPGKAYKHCSEVS
FSKIYRSRDVLDIELAGFRVINTLLELMIDAVTSPEKAYSQLLINRVSGQ
YNIKAPALYERVQAVLDYISGMTDVFALDLYRKINGNSLPAV
>BF0272 dut, putative deoxyuridine 5'-triphosphate nucleotidohydrolase
MNIQVINKSKHPLPAYATELSAGMDIRANISEPISLAPMQRCLVPTGLFI
ALPQGFEAQIRPRSGLALKKGITVLNSPGTIDADYRGEICIILVNLSAET
FVIEDGERIAQMVIARHEQAVWKEVEVLDETERGAGGFGHTGRG
>BF2256 fhs, formate--tetrahydrofolate ligase
MKSDIEIARSVELKKIKQVAESIGIPRDEVENYGRYIAKIPEYLIDEEKV
KKSNLILVTAITATKAGIGKTTVSIGLALGLNKIGKKAIVALREPSLGPC
FGMKGGAAGGGYAQVLPMEKINLHFTGDFHAITSAHNMISALLDNYLYQN
QSKGFGLKEILWRRVLDVNDRSLRNIVVGLGPKTNGITQESGFDITPASE
IMAILCLSKDVDDLRRRIENILLGYTYDNKPFTVKDLGVAGAITVLLKDA
IHPNLVQTTEGTAAFVHGGPFANIAHGCNSILATKMAMTFGDYVITEAGF
GADLGAEKFYNIKCRKSGLQPRLTVIVATAQGLKMHGGVSLDRIKEPNLE
GLREGLRNLDKHVRNLHSFGQTVIVAFNKFASDTDEEMELLREHCEQLGV
GYAINNAFSEGGEGAVDLANLVVETIENKPSEPLQFTYNDEDSVQQKIEK
VATNLYGASVVTYSTLTRNKIKLIEEMGIGHYPVCIAKTQYSFSADPKVY
GAVDNFELHIKDIVINNGAEMIVAIAGEIMRMPGLPKEPQALHIDIVDGN
IEGLS
>BF3500 gmk, putative guanylate kinase
MNPTERITTPHKTGEAKVIIFSAPSGSGKSTIINYLLAQKLNLAFSISAT
SRPPRGNEKHGVEYFFLSPDEFRQRIANNEFLEYEEVYTDRFYGTLKAQV
EKQLAAGQNVVFDVDVVGGCNIKKYYGERALSLFIQPPCIDELRRRLIGR
GTDTPEVIESRIAKAEYELSFAPKFDKVIINDDLETAKAHALKVIKEFLG
IDTE
>BF0887 guaA, putative GMP synthase [glutamine-hydrolyzing]
MQEKIIILDFGSQTTQLIGRRVRELDTYCEIVPYNKFPKGDETVKGVILS
GSPFSVYDESAFKVDLSEIRGKYPILGICYGAQFMAYTNGGKVEPAGTRE
YGRAHLTSFCKDNVLFKGVREGTQVWMSHGDTITAIPENFKTIASTDKVA
IAAYQVEGEQVWGVQFHPEVFHSEDGTQMLRNFVVDVCGCKQDWSPASFI
ESTVAELKAQLGDDKVVLGLSGGVDSSVAAVLLNRAIGKNLTCIFVDHGM
LRKNEFKNVMHDYECLGLNVIGVDASEKFFSELEGVTEPERKRKIIGKGF
IDVFDEEAHKLKDVKWLAQGTIYPDCIESLSITGTVIKSHHNVGGLPEKM
NLKLCEPLRLLFKDEVRRVGRELGMPEHLITRHPFPGPGLAVRILGDITP
EKVRILQDADDIFIQGLRDWGLYDQVWQAGVILLPVQSVGVMGDERTYER
AVALRAVTSTDAMTADWAHLPYEFLGKVSNDIINKVKGVNRVTYDISSKP
PATIEWE
>BF3891 guaB, putative inosine-5'-monophosphate dehydrogenase
MSFIADKIVMDGLTYDDVLLIPAYSEVLPRTVDLSTKFSRNIELKIPFVT
AAMDTVTEAKMAIAIAREGGIGVIHKNMSIKEQAKQVATVKRAENGMIYD
PVTIKQGSTVRDALALMAEYKIGGIPVVDDNRYLVGIVTNRDLRFERNMD
KRIDEVMTKENLVTTNQSTDLEAASQILQYHKIEKLPVVDKEGKLIGLVT
YKDITKAKDKPMACKDSKGRLRVAAGVGVTADTFDRMQALVDAGADAIVI
DTAHGHSKGVIDTLREAKKRYPDIDIVVGNIATGDAAKALVEAGADGVKV
GIGPGSICTTRVVAGVGVPQLSAVYDVAKALKGTGIPLIADGGLRYSGDV
VKALAAGGYSVMIGSLVAGTEESPGETIIFNGRKFKSYRGMGSLEAMENG
SKDRYFQSGEMDVKKLVPEGIAARVPYKGTLYEVIYQLTGGLRAGMGYCG
APDIEKLHDAKFTRITNAGVMESHPHDVTITSESPNYSRPE
>BF2280 prs, ribose-phosphate pyrophosphokinase
MVFSGTNSRYLAEKICASLNCPLGNMNITHFADGEFAVSYEESIRGAHVF
LVQSTFPNSDNLMELLLMIDAAKRASAKSVVAVIPYFGWARQDRKDKPRV
SIGAKLVADLLSVAGIDRLITMDLHADQIQGFFNIPVDHLYASAVFLPYI
QSLKLDELVIATPDVGGSKRASTFSKYLGVPLVLCNKSREKANEVASMQI
IGDVKGKNVVLIDDIVDTAGTITKAANIMLEAGANSVRAIASHCVMSDPA
SFRVQESGLTEMVFTDSIPYSKKCAKVKQLSIADMFAETIKRVMNNESIS
SQYII
>BF3274 punA, putative purine nucleoside phosphorylase I
MAMLEKIQETAAFLKGKMHTSPETAIILGTGLGSLANEITEKYEIKYEDI
PNFPVSTVEGHSGKLIFGKLGNKEIMAMQGRFHYYEGYSMKEVTFPVRVM
RELGIKTLFVSNASGGTNPEFEIGDLMIITDHINYFPEHPLRGKNIPYGP
RFPDMSEAYDKELIRKADAIAAEKGIKVQHGIYIGTQGPTFETPAEYKLF
HILGADAVGMSTVPEVIVANHCGIKVFGISVVTDLGVEGKIVEVSHEEVQ
KAADAAQPKMTTIMRELINRA
>BF3243 purA, putative adenylosuccinate synthetase
MKVDVLLGLQWGDEGKGKVVDVLTPKYDVVARFQGGPNAGHTLEFEGQKY
VLRSIPSGIFQGDKVNIIGNGVVLDPALFKAEAEALEASGHNLKERLHIS
KKAHLILPTHRILDAAYEAAKGDAKVGTTGKGIGPTYTDKVSRNGVRVGD
ILHNFEQKYAAAKARHEQILKGLNYEYDLTELEKAWFEGIEYLKQFQLVD
SEHEINGLLDNGKSILCEGAQGTMLDIDFGSYPFVTSSNTVCAGACTGLG
VAPNKIGDVYGIFKAYCTRVGSGPFPTELFDKTGDQICTLGHEFGSVTGR
KRRCGWVDLVALKYSIMVNGVTKLIMMKSDVLDTFETIKACVAYKMNGEE
IDYFPYDITDEVEPIYVELPGWQTDMTKMQSEDEFPEEFNAYLSFLEEQL
GVQIKIVSVGPDREQTIIRYTEE
>BF3792 purB, putative adenylosuccinate lyase
MKLDLLTAISPIDGRYRGKAEALAAYFSEYALIKYRVQVEVEYFITLCEL
PLPQLKGIDKSVFESLRNIYRNFTEADAQRIKDIESVTNHDVKAVEYFLK
EEFDKLGGLEEYKEFIHFGLTSQDINNTSIPLSIKEALEQVYYPLIEELI
AQLKTYATEWESIPMLAKTHGQPASPTRLGKEIMVFVYRLERQLATLKAC
PVTAKFGGATGNYNAHHVAYPEYDWKAFGNQFVAEKLGLEREEYTTQISN
YDNLSAIFDAMKRINTVMIDMNRDFWQYISMEYFKQKIKAGEVGSSAMPH
KVNPIDFENAEGNLGIANAILEHLAVKLPVSRLQRDLTDSTVLRNVGTPF
GHIVIAIQSSLKGLRKLLLNETAIYRDLDNCWSVVAEAIQTILRREAYPH
PYEALKALTRTNQAITETSIKEFIEGLDVNEEIKKELRVITPHSYTGI
>BF0096 purD, putative phosphoribosylamine--glycine ligase
MKILLLGSGGREHALAWKIAQSPKVEKLFIAPGNAGTGEVGENVNIKATD
FAALGAFALEESIDMIVVGPEDPLVEGIYDHFQSNPCLKNIAIIGPSKEG
ARLEGSKEFAKEFMHRHHIPTARYQSVTADTLNEGLAFLETLEAPYVLKA
DGLCAGKGVLILPTLEEAKKELKEMLGGMFGNASATVVIEEFLSGIECSV
FVLTDGDHYKVLPVAKDYKRIGEGDKGLNTGGMGSVTPVPFADEVFMEKV
RTRIIEPTVNGLKAEGITYKGFIFLGLINVKGEPMVIEYNVRMGDPETES
VMLRIQSDLVELLEGVAEGNLDARSLVIDPRTATCVMMVSGGYPEAYQKG
YAINGLEAARATDSILFHAGTAMKDGQAVTSGGRVLAICSYGNDKADALA
QCYKVADMIDFKDKNYRRDIGFDL
>BF4163 purE, putative transmembrane phosphoribosylaminoimidazole carboxylase
MTPIVSIIMGSTSDLPVMEKAAQLLNDLHVPFEMNALSAHRTPEAVEEFA
KNARSRGIKVIIAAAGMAAHLPGVIAASTPLPVIGVPIKSSLDGMDALLA
IVQMPPGIPVATVGINGALNAAILAVQMLSLEDKELETKFIAYKEGLKKK
IVKANEELKEIKYEFKTN
>BF1288 purF, putative amidophosphoribosyltransferase precursor
MGGFFGTVSKTSCVTDLFYGTDYNSHLGTKRGGLATYSEEQGFIRSIHNL
QSSYFRTKFEEELDKFKGNAGIGIISDTDAQPIIINSHLGRFAIVTVAKV
TNLKELEEELLSQNMHFAELSSGSTNQTELIALLIIQGKNFVEGIENVYN
HIKGSCSMLLLTEDGVIAARDKWGRTPIVIGKKEGAYAATSESNSFPNLD
FEIERYLGPGEIVRMQADRLEQLRKPDDKMQICSFLWVYYGFPNSCYEGR
NVEEVRFTSGLKMGEQDDCDADCVCGIPDSGIGQALGYAEGKGIPYHRAI
TKYTPTWPRSFTPSKQELRSLVAKMKLIPNRAMLQDKRIIFCDDSIVRGT
QLHDNVKILFDYGAKEVHMRIGCPPLIYGCPFIGFTASKSDMELITRQII
KELEGDENKNLDKYATTGSPEYEKMVGIIAKRFGLSSLKFNTIETLIEAI
GLPKCKVCTHCFDGSSCF
>BF3917 purH, putative bifunctional purine biosynthesis protein
MSESKRIKTALVSVYHKEGLDEIITKLHEEGVEFLSTGGTRQFIESLGYP
CKAVEDLTSYPSILGGRVKTLHPKIFGGILCRRGLEQDIQQIEKYEIPEI
DLVIVDLYPFEATVASGADEAAIIEKIDIGGISLIRAAAKNFNDVIIVAS
QAQYKPLLDMLMEHGATSSLEERRWMAKEAFAVSSHYDSAIFNYFDAEEG
SAFRCSANSQKTLRYGENPHQKGYFYGNLDEMFDQIHGKEISYNNLLDIN
AAVDLIDEFDDVTFAILKHNNACGLASRPTVLEAWKDALAGDPVSAFGGV
LITNAVIDKETAEEINKIFFEVVIAPDYDVDALEILGQKKNRIILVRKEA
KLPRKQFRSLLNGVLVQDRDLNIETTADLKTVTDKAPTPEEVEDMLFANK
IVKNSKSNAIVLAKGKQLLASGVGQTSRVDALKQAIEKAKSFGFDLQGAV
MASDAFFPFPDCVEIADKEGVTAVIQPGGSVKDQLTFDYCNEHGMAMVTT
GIRHFKH
>BF0180 purN, putative phosphoribosylglycinamide formyltransferase
MQSFAHFSLFCALKGLIMGKNIAIFASGSGTNAENIIRYFEKNASVRVRL
VLSNRKDAYVLERACRLGVPYRAFPKSDWEAAESILDLLRKYQIDFIVLA
GFLLRIPDALLHAYPDKIINIHPALLPKFGGKGMYGDRVHEAVVMAGESE
SGITIHYIDEHYDEGSTVFQAKCPVLPGDTPADVAKKVHALEYEWFPKII
ERVVNSL
>BF2226 purT, phosphoribosylglycinamide formyltransferase 2
MKKILLLGSGELGKEFVISAQRKGQHIIACDSYAGAPAMQVADECEVFDM
LNGEELERIVKKHRPDIIVPEIEAIRTERLYDFEKEGIQVVPSARAVNYT
MNRKAIRDLAAKELGLKTAKYYYAKSLEELKEAAEKIGFPCVVKPLMSSS
GKGQSLVKSAAELEHAWEYGCNGSRGDIRELIIEEFIKFDSEITLLTVTQ
KNGPTLFCPPIGHVQKGGDYRESFQPAHIDPAHLKEAEDMAEKVTRALTG
AGLWGVEFFLSHENGVYFSELSPRPHDTGMVTLAGTQNLNEFELHLRAVL
GLPIPGIKQERIGASAVILSPIASQERPQYRGMEEVTGEEDTYLRIFGKP
YTRVNRRMGVVLCYAPNGSDLDALRDKAKRIADKVEVY
>BF2262 pyrB, aspartate carbamoyltransferase catalytic chain
MENRSLVTIAEHSREKILYMLEMAKQFEKNPNRRLLEGKVVATLFFEPST
RTRLSFETAANRLGARVIGFSDPKATSSSKGETLKDTIMMVSNYADVIVM
RHYLEGAARYASEVAPVPIVNAGDGANQHPSQTMLDLYSIYKTQGTLENL
NIYLVGDLKYGRTVHSLLMAMRHFNPTFHFIAPEELKMPEEYKIYCKEHN
IKYVEHTDFNEEVIKDADILYMTRVQRERFTDLMEYERVKNVYILKAKML
ENTRSNLRILHPLPRVNEIAYDVDDSPKAYYFQQAQNGLYARQAILCDVL
GITLQDIL
>BF2483 pyrD1, putative dihydroorotate dehydrogenase, catalytic subunit
MADLSVNIGKLQMKNPVMTASGTFGYGEEFADFIDITRIGGIIVKGTTLH
KREGNPYPRMAETPSGMLNAVGLQNKGVEYFSNHIYPRIKDIQTHMIVNV
SGSAIEDYVKTAEIINELDKIPAIELNISCPNVKQGGMAFGVTTKGVSEV
VQAVRSAYKKTLIVKLSPNVTDIAEMARAAEANGADSVSLINTLLGMAID
AERKRPILSTVTGGMSGAAVKPIALRMVWQVAKAVNIPVIGLGGIMNWKD
AVEFMLAGASAIQIGTANFIDPAITIKVIDGINDYLERHGCKSVSEIIGA
LEV
>BF2218 pyrD2, putative dihydroorotate dehydrogenase, catalytic subunit
MYKQTIRPVLFLMEPEKVHALLVSCLKCYRHLPWCRCWIRHLYTCSDKQL
IWNHLTFRNRIGLSAGFDKGAEIFDELADCGFGFIEVGTVTPDSQDGNPR
PRIFRLPQCESLISRTGFNNPGLDVIKRRLEQKSGSYVLGVNINKNPSSE
GEQAVADFLRLYKELHPHVGYFTLNWGSVDVALMKQVLQGLAVFRVEQNI
HVPLLLKLPADITEEGMDDVIDCTRLYRVDGVIATGPTMERSYLKGYSPA
QLQKIGSGGISGRGIGERSLKAVSYLRAHAGKSLLIVGAGGIITPADARR
MLDAGANLIQIYSSFIYEGPGIVKKMIQEIK
>BF0455 pyrE, putative orotate phosphoribosyltransferase
MKNLERLFAEKLLKIKAIKLQPANPFTWASGWKSPFYCDNRKTLSYPSLR
SFVKFEITRLVLERFGQVDAIAGVATGAIPQGALVADALNLPFVYVRSTP
KDHGLENLIEGELRPGMKVVVVEDLISTGGSSLKAVEAIRRDGCEVIGMV
AAYTYGFPVAEQAFKDAKVPLVTLTNYEAVLDVALRTGYIEEEDIATLNE
WRKDPAHWETGK
>BF2624 pyrG, CTP synthase
MGETKYIFVTGGVASSLGKGIISSSIGKLLQARGYKVTIQKFDPYINIDP
GTLNPYEHGECYVTVDGHEADLDLGHYERFLGIQTTKANNITTGRIYKSV
IDKERRGDYLGKTIQVIPHITDEIKRNVKLLGNKYKFDFVITEIGGTVGD
IESLPYLESIRQLKWELGQNALCVHLTYVPFLSAAQELKTKPTQHSVKEL
QSLGVQPDILVLRTEHDLNTNLRKKVALFCNVAENAVVQSIDASTIYEVP
LLMQEQGLDETILQKMGLPVGERPPLGPWKDFLNRRANATETVTIAMVGK
YVELQDAYKSILESLSQAATYNDRKVKIEYVSSEHLTPDNVDEQLGHVNG
VVICPGFGSRGIEGKFVAAKYTREHNIPTFGICLGMQCMAIEFARNVLGY
ADANSIEMDEKTKHNVIDIMEEQKAITNMGGTMRLGAYECVLKKDSKVYE
AYKEEHIQERHRHRYEFNNDYRKQFEEAGMKCVGINPESDLVEIVEIPTL
KWYIGTQFHPEYSSTVLHPHPLFVSFIKAAIDK
>BF2261 pyrI, aspartate carbamoyltransferase regulatory chain
MSENKQALQVAALKNGTVIDHIPSEKLFTVVSLLGLEHMTTNITIGFNLD
SKKLGKKGIIKIADKFFCDEEINRISVVAPHVKLNIIRDYEVVEKKEVRM
PDELKAIVKCANPKCITNNEPMATLFHVIDKDNCVIKCHYCEKEQKREDI
TII
>BF0583 tdk, putative thymidine kinase
MVLFSEDHIQETRRRGRIEVICGSMFSGKTEELIRRMKRAKFARQRVEIF
KPAIDTRYSEGDVVSHDSNSISSTPIDSSASILLFTSEIDVVGIDEAQFF
DSGLIDVCNQLANNGVRVIIAGLDMDFKGIPFGPMPALCAIADEVSKVHA
ICVKCGQLASFSHRTVKNDKQVLLGETAQYEPLCRECYQRALQEDREKS
>BF3523 thyB, putative thymidylate synthase B
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKL
HLKSIIYELLWFLKGDTNVKYLQDHGVRIWNEWADETGDLGHIYGYQWRS
WPTYDGGFIDQISEAVDAIKHNPDSRRIIVSAWNVGDLDHMNLPPCHAFF
QFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLQAGDFI
HTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFQFEDFELV
NYDPHPHIAGKVAV
>BF3035 udk, putative uridine kinase
MLIIGIAGGTGSGKTTVVRKIIESLPAGEVVLLPQDSYYKDSSHVPVEER
QNINFDHPDAFEWSLLSKHVALLKEGKCIEQPTYSYLTCTRQPETIHIEP
REVVIIEGILALCDKKLRNMMDLKIFVDADPDERLIRVIQRDVVERGRTA
EAVMERYTRVLKPMHLQFIEPCKRYADLIVPEGGSNQVAIDILTMYIKKH
IGRP
>BF1550 upfZ, putative transcriptional regulator
MNYLESEISALYASAHELCYLGMDGRPIYSDQFTRLNRDVFSQANALYDK
RGNSHEEEARLCLSLLMGYNATLYNNGDKEERIQHILDRCWDVLEHLPAS
LLKVQLLVYCYGEVFDEELAREAQAIIDTWQDRKLSEEEREVVERLKDVQ
ENPYPWSEVE
>BF0732 upgZ, putative transcriptional regulator
MTLSEEVASLQRAAHDLMYLGMDGSPIYSDDLSRRNNEVYRLTTTLYNSG
VQGSTVEEQASVCLALLMGYNASFIDHGEKREHVQKILDRCWDILDTLPA
SLLKLRLLTACYGEVFDEPLADEARAIIASWDSVSLTTEQQEAINEFQTV
VDNPYPWEYVEE
>BF3465 uphZ, putative LPS biosynthesis related transcriptional regulatory protein
MNSLDSQITALYTLAHELLYLGSDGSPIYSDHFSRLNGDVLSRANTLYPH
HGSTDEEEARLCLSLLMGYNATIYNNGDKEVRIQQILNRCWEVLDRLPAS
LLKVRLLTYCYGEVFDDDLSREAHSIIDSWGERALSGDECEIAEQLRSLE
ENPYPNWEVEE